(S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate) (Compound)
Analyze
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate)'s neighborhood in the knowledge graph.
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for (S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate).
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with (S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate).
Results found
Linked to
(S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate) bioactivity Muscarinic acetylcholine receptor M5
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
(S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate) bioactivity Muscarinic acetylcholine receptor M2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
(S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate) bioactivity Muscarinic acetylcholine receptor M3
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
(S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate) bioactivity Muscarinic acetylcholine receptor M1
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
(S)-2-Acetamido-N-((S)-3-(4-hydroxyphenyl)-1-oxo-1-((2-(4-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)piperazin-1-yl)ethyl)amino)propan-2-yl)-3-(1H-indol-3-yl)propanamide tris(hydrotrifluoroacetate) bioactivity Muscarinic acetylcholine receptor M4
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG